Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7076
Rank
โ‚น56.37 B
Marketcap
โ‚น1,611
Share price
-0.91%
Change (1 day)
-44.60%
Change (1 year)

EPS for Avalon Pharma (Middle East Pharmaceutical) (4016.SR)

EPS in 2026 (TTM): โ‚น46.16

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current EPS (TTM) is โ‚น46.70. In 2025 the company made an earnings per share (EPS) of โ‚น68.53 an increase over its 2024 EPS that were of โ‚น56.31.

EPS history for Avalon Pharma (Middle East Pharmaceutical) from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น46.16-32.63%
2025โ‚น68.5321.69%
2024โ‚น56.3121.02%
2023โ‚น46.53